Ticker

Indaptus Therapeutics (NASDAQ: INDP - Get Free Report) is expected to be issuing its results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of ($4.36) per share for the quarter. Indaptus Therapeutics Stock Up 6.9% INDP opened at $2.01 on Thursday. The firm has a market cap of $4.50

NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announces it has entered into a $6 million securities purchase agreement with investor, David E. Lazar, for the purchase of non-voting convertible preferred stock of the Company. Mr.…